Menu
Lactiga is an award-winning, venture-backed biotherapeutics company committed to restoring mucosal immunity in patients with rare immunodeficiency diseases. We are unlocking the full therapeutic value of IgA antibodies developed from human milk to create the next generation of anti-infectives to fight debilitating pathogens including SARS-CoV-2 and its variants.
Lactiga holds 3 granted patents in support of its LCTG-001 program to prevent life-threatening, respiratory mucosal infections in patients with immunodeficiencies like common variable immune deficiency (CVID) and its NIH-funded program LCTG-002 to develop an airway therapeutic to reduce hospitalizations and infections from COVID-19 and its variants in vulnerable populations.
Co-founder and CSO
Co-founder and CEO
Chief Development Officer
Intellectual Property
Since 2011, Innovation Factory’s LiONS LAIR has helped more than 150 startups launch and scale their businesses. This fall, join over 350 entrepreneurs, investors and thought leaders to network over dinner and drinks, celebrate innovation, and watch finalists pitch live to a panel of judges to win cash and in-kind prizes.
When: September 26, 2024 | 5:00pm – 9:00pm
Where: LiUNA Station – 360 James St. N, Hamilton, Ontario L8L 1H5
Network with 250+ industry professionals, discover emerging solutions from our innovators, and celebrate entrepreneurship within the Hamilton-Halton ecosystem.
